After a long biotech IPO lull, LB Pharma chances its arm After a promising start, IPOs all but fizzled out this year, but LB Pharma is hoping that won't stymy its chances of completing a Nasdaq listing.

#PharmaPhorum #biotech #IPO #LBPharma #LBPharmaceuticals #Nasdaqlisting #biotechIPOs #USA #drugdevelopment #LB102 #antipsychoticdrug #amisulpride #centralnervoussystem #schizophrenia #Amisulpride #clinicaldevelopment #bipolardepression #PositiveandNegativeSyndromeScale #PANSS
zurl.co/oJUIU